The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(7-Methoxy-9H-thioxanthen-4-yl)-2-morpholino-pyrimidin-4-ol ID: ALA4874992
PubChem CID: 164627203
Max Phase: Preclinical
Molecular Formula: C22H21N3O3S
Molecular Weight: 407.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c(c1)Cc1cccc(-c3cc(O)nc(N4CCOCC4)n3)c1S2
Standard InChI: InChI=1S/C22H21N3O3S/c1-27-16-5-6-19-15(12-16)11-14-3-2-4-17(21(14)29-19)18-13-20(26)24-22(23-18)25-7-9-28-10-8-25/h2-6,12-13H,7-11H2,1H3,(H,23,24,26)
Standard InChI Key: YBKLBECNVUXSJN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
32.0809 -10.1612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.0809 -10.9826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7904 -11.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4998 -10.9826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4998 -10.1612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7904 -9.7485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2106 -11.3952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2074 -12.2174 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9105 -12.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6253 -12.2229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6284 -11.4006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9168 -10.9824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.3400 -10.9940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7679 -10.1811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0531 -9.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3427 -10.1760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7635 -11.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0463 -11.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0419 -12.2345 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
38.4763 -11.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4703 -12.2437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7531 -12.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7459 -13.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4551 -13.8864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1730 -13.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1767 -12.6556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8787 -13.8913 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.8747 -14.7126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9052 -13.4441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
7 12 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
4 7 1 0
13 18 2 0
17 14 2 0
14 15 1 0
15 16 2 0
16 13 1 0
11 13 1 0
17 18 1 0
17 20 1 0
18 19 1 0
19 22 1 0
21 20 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
25 27 1 0
27 28 1 0
9 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 407.50Molecular Weight (Monoisotopic): 407.1304AlogP: 3.75#Rotatable Bonds: 3Polar Surface Area: 67.71Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.15CX Basic pKa: 1.97CX LogP: 5.09CX LogD: 5.09Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -1.16
References 1. Van de Poël A, Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Peacock M, Barnard A, Cox HC, Jones G, McAllister G, Vater H, Esmieu W, Clissold C, Lamers M, Leonard P, Jarvis RE, Blackaby W, Eznarriaga M, Lazari O, Yates D, Rose M, Jang SW, Muñoz-Sanjuan I, Dominguez C.. (2021) Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease., 64 (8.0): [PMID:33783225 ] [10.1021/acs.jmedchem.1c00114 ]